Literature DB >> 28139380

Breast Cancer Incidence and Predictors of Surgical Outcome: a Nationwide Longitudinal Study in Taiwan.

Hong-Tai Chang1, Hon-Yi Shi2, Being-Whey Wang3, Shu-Chuan Jennifer Yeh4.   

Abstract

AIMS: Despite the huge and growing global burden of patients who require breast cancer surgery, high-quality population-based studies of breast cancer trends and outcomes are scarce. The purpose of this study was to explore the incidence of breast cancer and predictors of hospital resource utilisation, mortality and recurrence in a nationwide population of patients who have received surgery.
MATERIALS AND METHODS: This retrospective study analysed trends and outcomes in a Taiwan population of 77 971 patients after breast cancer surgery during 1996-2010. The Cox proportional hazards model was used for multivariate assessment of both mortality and recurrence predictors.
RESULTS: The data analysis indicated that, during this period, the estimated mean hospital treatment cost and mean length of stay increased by 16.3% and 53.4%, respectively. The estimated mean overall survival time was 138.9 months (standard deviation 0.3 months) and the overall 1, 3, 5 and 10 year survival rates were 97.3, 89.2, 82.2 and 70.1%, respectively. The estimated mean overall recurrence time was 10.8 months (standard deviation 0.2 months) and the overall 1, 3, 5 and 10 year recurrence rates were 0.1, 18.8, 26.6 and 36.0%, respectively. Outcomes were significantly associated with age, Deyo-Charlson comorbidity index score, surgeon seniority, hospital volume, surgeon volume, surgery type, hospital level and baseline comorbidities (P<0.001).
CONCLUSIONS: Analyses of these population-based data revealed simultaneous increases in the standard incidence of breast cancer surgery and its associated medical resource utilisation. Notably, healthcare providers and patients should recognise that both patient attributes and hospital attributes may affect breast cancer surgery outcomes.
Copyright © 2017 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Breast cancer; hospital resource utilisation; mortality rate; recurrence rate surgery; trends

Mesh:

Year:  2017        PMID: 28139380     DOI: 10.1016/j.clon.2017.01.005

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  7 in total

1.  Comparison of Models for Predicting Quality of Life After Surgical Resection of Hepatocellular Carcinoma: a Prospective Study.

Authors:  Chong-Chi Chiu; King-Teh Lee; Hao-Hsien Lee; Jhi-Joung Wang; Ding-Ping Sun; Chien-Cheng Huang; Hon-Yi Shi
Journal:  J Gastrointest Surg       Date:  2018-06-18       Impact factor: 3.452

2.  Application value of modified radical mastectomy in female patients with breast cancer of different molecular types: a prognosis study.

Authors:  Bing Dong; Xiaoxing Yin; Han Xu; Kun Zhou; Longzhi Li; Baoxing Tian; Rongrong Cui
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 3.940

3.  Risk of Breast Cancer in Women with Mastitis: A Retrospective Population-Based Cohort Study.

Authors:  Ying-Cheng Chen; Chi-Ho Chan; Yu-Bing Lim; Shun-Fa Yang; Liang-Tsai Yeh; Yu-Hsun Wang; Ming-Chih Chou; Chao-Bin Yeh
Journal:  Medicina (Kaunas)       Date:  2020-07-24       Impact factor: 2.430

4.  Propofol-based total intravenous anesthesia did not improve survival compared to desflurane anesthesia in breast cancer surgery.

Authors:  Yi-Hsuan Huang; Meei-Shyuan Lee; Yu-Sheng Lou; Hou-Chuan Lai; Jyh-Cherng Yu; Chueng-He Lu; Chih-Shung Wong; Zhi-Fu Wu
Journal:  PLoS One       Date:  2019-11-07       Impact factor: 3.240

5.  Nonsteroidal Anti-Inflammatory Drugs Reduce Second Cancer Risk in Patients With Breast Cancer: A Nationwide Population-Based Propensity Score-Matched Cohort Study in Taiwan.

Authors:  Yin-Che Lu; Pin-Tzu Chen; Mei-Chen Lin; Che-Chen Lin; Shi-Heng Wang; Yi-Jiun Pan
Journal:  Front Oncol       Date:  2021-11-24       Impact factor: 6.244

6.  Clinical Outcomes of Neoadjuvant Therapy in Human Epidermal Growth Factor Receptor 2 Breast Cancer Patients: A Single-Center Retrospective Study.

Authors:  Chih-Chiang Hung; I-Chen Tsai; Chiann-Yi Hsu; Hsin-Chen Lin
Journal:  J Clin Med       Date:  2022-03-05       Impact factor: 4.241

7.  Stratified analysis of the association between periodontitis and female breast cancer based on age, comorbidities and level of urbanization: A population-based nested case-control study.

Authors:  Chien-Chih Chen; Wei-Li Ho; Ching-Heng Lin; Hsin-Hua Chen
Journal:  PLoS One       Date:  2022-07-26       Impact factor: 3.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.